Skip to content

AMH, Glucose Intolerance and Metabolic Syndrome in PCOS

Anti-Müllerian Hormone and Its Association With Glucose Intolerance and Metabolic Syndrome in Women With Polycystic Ovary Syndrome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02676518
Enrollment
70
Registered
2016-02-08
Start date
2015-04-30
Completion date
2016-05-31
Last updated
2016-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome

Keywords

polycystic ovary syndrome, Serum anti-Mullerian hormone, glucose intolerance, metabolic syndrome

Brief summary

Association between serum anti-Mullerian hormone (AMH) level and prevalence of glucose intolerance and metabolic syndrome in women with polycystic ovary syndrome (PCOS)

Detailed description

* To study the association between serum anti-Mullerian hormone (AMH) level and glucose intolerance and metabolic syndrome in women with polycystic ovary syndrome (PCOS). * Glucose intolerance is detected by 2-hours 75 gram oral glucose tolerance test (OGTT). * Metabolic syndrome is diagnosed by using the Harmonized criteria; the presence of any 3 of 5 following risk factors constitutes a diagnosis of metabolic syndrome. 1. Elevated waist circumference (\> 80 cm in Asian women) 2. Elevated triglycerides (\> 150 mg/dL) 3. Reduced HDL-cholesterol (\< 50 mg/dL) 4. Elevated blood pressure )systolic \> 130 and/or diastolic \> 85 mmHg) 5. Elevated fasting glucose ( \> 100 mg/dL) * Percentage of glucose intolerance and metabolic syndrome in PCOS women as well was any differences in parameters between PCOS patients with and without glucose intolerance and metabolic syndrome will be analysed.

Interventions

OTHERserum

Serum for serum anti-Mullerian hormone, 2-hour 75 gram oral glucose tolerance test and lipid profiles

Sponsors

Chulalongkorn University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* PCOS diagnosed by Rotterdam criteria 2003

Exclusion criteria

* Pregnancy * Previous any hormonal uses in the last 3 months * Previous hypoglycemic drugs or insulin-sensitising agents use in the last 3 months * Previous chemotherapy, ovarian surgery, pelvic irradiation * Menopause

Design outcomes

Primary

MeasureTime frameDescription
Differences between serum AMH level between PCOS women with and without glucose intolerance and metabolic syndrome6 monthsAny differences between mean of serum AMH levels in PCOS with and without glucose intolerance and metabolic syndrome

Secondary

MeasureTime frameDescription
Percentage of glucose intolerance in PCOS women6 monthsPercentage of glucose intolerance detected by 75 g OGTT in PCOS women
Percentage of metabolic syndrome in PCOS women6 monthsPercentage of metabolic syndrome defined by the Harmonized criteria in PCOS women

Countries

Thailand

Contacts

Primary ContactWasamon Tunsuparp, MD
wasamontun@gmail.com66850658502
Backup ContactPorntip Sirayapiwat, MD, MSc
p_siraya@hotmail.com66818378923

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026